Skye Bioscience Inc.(SKYE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SKYE Skye Bioscience Inc.

盘前交易 06-03 04:01:51 EDT

0.7138

-0.0462

-6.08%

最高0.7590	最低0.6810	成交量35.30万
今开0.7448	昨收0.7600	日振幅10.26%
总市值2,507万	流通市值1,638万	总股本3,513万
成交额24.99万	换手率1.54%	流通股本2,295万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SKYE","market":"US","secType":"STK","nameCN":"Skye Bioscience Inc.","latestPrice":0.7138,"timestamp":1780430400000,"preClose":0.76,"halted":0,"volume":353005,"delay":0,"changeRate":-0.06078947368421055,"floatShares":22951600,"shares":35126884,"eps":-1.449957,"marketStatus":"盘前交易","change":-0.0462,"latestTime":"06-03 04:01:51 EDT","open":0.7448,"high":0.759,"low":0.681,"amount":249880.7880178,"amplitude":0.102632,"askPrice":0,"askSize":0,"bidPrice":0.68,"bidSize":5,"shortable":0,"etf":0,"ttmEps":-1.449957,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780493400000},"marketStatusCode":1,"symbolChange":{"newSymbol":"SKYED","executeDate":"2023-09-08"},"adr":0,"exchange":"NASDAQ","adjPreClose":0.7138,"postHourTrading":{"tag":"盘后","latestPrice":0.7455,"preClose":0.7138,"latestTime":"19:50 EDT","volume":5097,"amount":3801.1418,"timestamp":1780444214713,"change":0.0317,"changeRate":0.04441,"amplitude":0.065705},"volumeRatio":1.857221,"impliedVol":1.3048,"impliedVolPercentile":0.572},"requestUrl":"/m/hq/s/SKYE","defaultTab":"news","newsList":[{"id":"1199526390","title":"Skye Bioscience Inc. - 临床研究委员会批准启动第二组（600毫克静脉注射）入组，此前第一组安全性评估结果良好","url":"https://stock-news.laohu8.com/highlight/detail?id=1199526390","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199526390?lang=zh_cn&edition=full","pubTime":"2026-05-20 19:01","pubTimestamp":1779274904,"startTime":"0","endTime":"0","summary":"在完成对第一组受试者的安全性评估并获得良好反馈后，临床研究委员会已正式批准Skye Bioscience Inc.启动其研究项目的第二组患者入组工作。该组别将采用600毫克的静脉注射剂量方案。这一决定标志着该药物临床开发进程向前迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155074624","title":"Skye宣布基于队列1前四名受试者良好安全性数据，队列评审委员会批准开启队列2","url":"https://stock-news.laohu8.com/highlight/detail?id=1155074624","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155074624?lang=zh_cn&edition=full","pubTime":"2026-05-20 19:00","pubTimestamp":1779274829,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc. 宣布，其队列评审委员会已批准开启临床试验的队列2。这一决定是基于从队列1中首批接受治疗的四名参与者所获得的积极安全性数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167741515","title":"Skye公布Nimacimab联合司美格鲁肽Cbeyond二期a阶段扩展研究积极中期结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1167741515","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167741515?lang=zh_cn&edition=full","pubTime":"2026-02-02 20:08","pubTimestamp":1770034126,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc.（简称“Skye”）近日披露了其创新药物Nimacimab与司美格鲁肽（Semaglutide）联合用药的Cbeyond二期a阶段扩展研究的中期分析数据，结果显示疗效积极。\n这项扩展研究旨在评估Nimacimab与司美格鲁肽联合治疗方案在特定患者群体中的长期安全性与有效性。中期数据表明，联合用药在关键疗效指标上表现出显著改善，且安全性和耐受性良好，未出现新的不良反应信号。\n研究结果的积极进展为Nimacimab的后续临床开发提供了有力支持，也为相关疾病领域的治疗带来了新的潜在选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106684585","title":"Skye Bioscience Inc. 联合疗法52周减重22.3%：Nimacimab联合司美格鲁肽（2.4毫克）展现显著成效","url":"https://stock-news.laohu8.com/highlight/detail?id=1106684585","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106684585?lang=zh_cn&edition=full","pubTime":"2026-02-02 20:06","pubTimestamp":1770034013,"startTime":"0","endTime":"0","summary":"在为期52周的临床研究中，Skye Bioscience Inc. 所开发的Nimacimab与司美格鲁肽（2.4毫克）联合疗法取得了令人瞩目的成果，受试者体重平均下降幅度达到22.3%。这一数据凸显了该联合方案在体重管理领域的巨大潜力。\nNimacimab作为一种创新治疗成分，与已广泛应用的司美格鲁肽协同作用，显示出优于单一疗法的减重效果。研究结果不仅证实了联合用药的安全性，更为其在肥胖治疗领域的应用前景提供了有力支持。\n未来，Skye Bioscience Inc. 将继续推进相关临床研究，进一步探索该联合疗法的长期疗效与适用范围，为全球肥胖患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158508067","title":"Skye Bioscience Inc.计划于2026年年中启动Nimacimab联合Enhanze技术治疗肥胖症的2B期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1158508067","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158508067?lang=zh_cn&edition=full","pubTime":"2026-01-05 20:03","pubTimestamp":1767614583,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc.近日公布其研发战略，计划在2026年中期正式启动一项针对肥胖症治疗的2B期临床试验。该试验将重点评估其核心候选药物Nimacimab与奥洛兹美医疗（Halozyme Therapeutics）专有的Enhanze药物递送技术联合应用的疗效与安全性。\n这一临床进展标志着Skye在代谢疾病治疗领域迈出了关键一步。Nimacimab作为一种创新疗法，结合Enhanze技术旨在增强药物递送效率，有望为肥胖患者提供新的治疗选择。公司预计该试验将为后续临床开发提供重要数据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE","HALO","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162485011","title":"奥洛兹美医疗与Skye Bioscience达成全球合作与许可协议，共同评估Nimacimab与Enhanze®复方制剂用于肥胖症治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1162485011","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162485011?lang=zh_cn&edition=full","pubTime":"2026-01-05 20:02","pubTimestamp":1767614523,"startTime":"0","endTime":"0","summary":"奥洛兹美医疗与Skye Bioscience公司宣布，双方已签署一项全球性的合作与许可协议。该协议的核心内容是，将共同评估Nimacimab与奥洛兹美医疗的Enhanze®药物递送技术共同配制的复方制剂，用于治疗肥胖症的潜力。此次合作旨在结合两家公司的专长，探索这一创新疗法在代谢疾病领域的应用前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139","HALO","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512962111","title":"Skye Bioscience, Inc.盘中异动 快速跳水6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512962111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512962111?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:14","pubTimestamp":1739906081,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时14分，Skye Bioscience, Inc.股票出现波动，股价大幅跳水6.01%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为840.04%、208.50%、168.28%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031441988a2a2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031441988a2a2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511152040","title":"Skye Bioscience, Inc.盘中异动 临近午盘股价大涨6.63%报3.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511152040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511152040?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:38","pubTimestamp":1739464710,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日00时38分，Skye Bioscience, Inc.股票出现波动，股价快速上涨6.63%。截至发稿，该股报3.04美元/股，成交量1.8639万股，换手率0.06%，振幅6.14%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214003830abcdcb06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214003830abcdcb06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510333098","title":"Skye Bioscience, Inc.盘中异动 快速下跌9.62%报3.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510333098","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510333098?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:14","pubTimestamp":1739286855,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时14分，Skye Bioscience, Inc.股票出现波动，股价大幅下挫9.62%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为1.52%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2544.19%、825.94%、338.91%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为52.11%、43.92%、37.99%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211231415961f5018&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211231415961f5018&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCEA","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510086093","title":"Skye Bioscience, Inc.盘中异动 股价大涨5.41%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510086093","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510086093?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:05","pubTimestamp":1739207122,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日01时05分，Skye Bioscience, Inc.股票出现异动，股价急速上涨5.41%。截至发稿，该股报3.31美元/股，成交量6.7361万股，换手率0.22%，振幅6.92%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211010522a240c223&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211010522a240c223&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509744745","title":"Skye Bioscience, Inc.盘中异动 早盘快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509744745?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:40","pubTimestamp":1738939204,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时40分，Skye Bioscience, Inc.股票出现波动，股价急速上涨5.03%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Engene Holdings Inc C/Wts 31/10/2028  Cl A涨幅较大，Conduit Pharmaceuticals Inc.、Lipella Pharmaceuticals Inc.、Aditxt, Inc.较为活跃，换手率分别为1717.95%、52.33%、38.10%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为130.43%、50.97%、20.91%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224005987daf2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224005987daf2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509203364","title":"Skye Bioscience, Inc.盘中异动 股价大涨6.01%报3.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509203364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509203364?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:15","pubTimestamp":1738854944,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时15分，Skye Bioscience, Inc.股票出现异动，股价急速上涨6.01%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Lipella Pharmaceuticals Inc.、Azitra Inc、Transcode Therapeutics, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为5233.13%、1204.05%、130.03%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为98.06%、39.93%、36.09%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206231544987c9688&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206231544987c9688&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509928210","title":"Skye Bioscience, Inc.盘中异动 大幅下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509928210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509928210?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:32","pubTimestamp":1738765926,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时32分，Skye Bioscience, Inc.股票出现波动，股价快速跳水5.15%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Pasithea Therapeutics Corp.、60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.较为活跃，换手率分别为2669.24%、598.88%、588.13%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Eyepoint Pharmaceuticals, Inc.、Oragenics Inc.，振幅分别为16.82%、11.81%、9.75%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223206a23a7a90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223206a23a7a90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KTTA","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508141831","title":"Skye Bioscience, Inc.盘中异动 早盘急速拉升8.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141831","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508141831?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593167,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分，Skye Bioscience, Inc.股票出现波动，股价急速拉升8.50%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为319.55%、229.78%、126.66%，振幅较大的相关个股有Hcw Biologics Inc.、Briacell Therapeutics Corp.、Briacell Therapeutics Corp C/Wts 24/02/2025，振幅分别为35.77%、12.95%、12.28%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322324798796f2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322324798796f2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507966635","title":"Skye Bioscience, Inc.盘中异动 早盘急速上涨6.13%报3.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507966635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507966635?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:37","pubTimestamp":1738334231,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时37分，Skye Bioscience, Inc.股票出现波动，股价快速上涨6.13%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为1421.87%、266.60%、64.50%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nutriband Inc C/Wts 、Nls Pharmaceutics Ltd.，振幅分别为62.40%、42.27%、30.81%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223711a2354358&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223711a2354358&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507622262","title":"Skye Bioscience, Inc.盘中异动 早盘快速拉升5.54%报3.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507622262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507622262?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:10","pubTimestamp":1738249822,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时10分，Skye Bioscience, Inc.股票出现异动，股价急速拉升5.54%。截至发稿，该股报3.62美元/股，成交量6.7146万股，换手率0.22%，振幅7.87%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302310229614420c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302310229614420c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507631417","title":"Skye Bioscience, Inc.盘中异动 股价大涨5.33%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507631417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507631417?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:33","pubTimestamp":1738161211,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时33分，Skye Bioscience, Inc.股票出现异动，股价急速上涨5.33%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.涨幅较大，Silexion Therapeutics Corp、60 Degrees Pharmaceuticals, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为2058.38%、1489.04%、626.02%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.，振幅分别为114.29%、50.00%、30.73%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223331961395fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223331961395fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506992510","title":"Skye Bioscience, Inc.盘中异动 股价大涨6.17%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506992510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506992510?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:37","pubTimestamp":1738078654,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时37分，Skye Bioscience, Inc.股票出现异动，股价大幅拉升6.17%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Silexion Therapeutics Corp、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3800.52%、2721.45%、260.36%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Silexion Therapeutics Corp、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为122.16%、82.74%、61.62%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128233735abbb74ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128233735abbb74ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506301408","title":"Skye Bioscience, Inc.盘中异动 早盘大幅下挫6.12%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506301408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506301408?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:50","pubTimestamp":1737993040,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时50分，Skye Bioscience, Inc.股票出现异动，股价大幅下挫6.12%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Akero Therapeutics, Inc.、Dogwood Therapeutics, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As较为活跃，换手率分别为1918.40%、367.40%、214.27%，振幅较大的相关个股有Onconetix, Inc.、Dogwood Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为85.35%、75.00%、65.16%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127235040a2317ad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127235040a2317ad1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505869524","title":"Skye Bioscience, Inc.盘中异动 早盘快速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505869524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505869524?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:43","pubTimestamp":1737729781,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时43分，Skye Bioscience, Inc.股票出现波动，股价大幅上涨5.14%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Evaxion Biotech As、Pmgc Holdings Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Avenue Therapeutics, Inc.较为活跃，换手率分别为2265.82%、1360.83%、859.79%，振幅较大的相关个股有Pmgc Holdings Inc.、Transcode Therapeutics, Inc.、Evaxion Biotech As，振幅分别为40.91%、38.55%、35.16%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124224301a22e5d08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124224301a22e5d08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.skyebioscience.com","stockEarnings":[{"period":"1week","weight":-0.1317},{"period":"1month","weight":-0.1332},{"period":"3month","weight":-0.0362},{"period":"6month","weight":-0.4101},{"period":"1year","weight":-0.6813},{"period":"ytd","weight":-0.0479}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.054},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.1098},{"period":"1year","weight":0.2815},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Skye Bioscience, Inc.于2011年3月16日在内华达州注册成立。该公司是一家临床阶段的生物制药公司，其使命是率先开发新药，释放ECS的制药潜力。他们的临床资产专注于CB1的调节，为代谢紊乱、炎症、纤维化和神经退行性变（如肥胖和青光眼）引起的疾病提供新的治疗方法和替代品。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.392456},{"month":2,"riseRate":0.333333,"avgChangeRate":0.405082},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.151124},{"month":4,"riseRate":0.5,"avgChangeRate":0.066911},{"month":5,"riseRate":0.5,"avgChangeRate":-0.010396},{"month":6,"riseRate":0.5,"avgChangeRate":0.212011},{"month":7,"riseRate":0.4,"avgChangeRate":-0.080829},{"month":8,"riseRate":0.2,"avgChangeRate":-0.076771},{"month":9,"riseRate":0.2,"avgChangeRate":-0.127741},{"month":10,"riseRate":0.2,"avgChangeRate":-0.245291},{"month":11,"riseRate":0.2,"avgChangeRate":-0.107928},{"month":12,"riseRate":0.2,"avgChangeRate":-0.107415}],"exchange":"NASDAQ","name":"Skye Bioscience Inc.","nameEN":"Skye Bioscience Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Skye Bioscience Inc.(SKYE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Skye Bioscience Inc.(SKYE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Skye Bioscience Inc.,SKYE,Skye Bioscience Inc.股票,Skye Bioscience Inc.股票老虎,Skye Bioscience Inc.股票老虎国际,Skye Bioscience Inc.行情,Skye Bioscience Inc.股票行情,Skye Bioscience Inc.股价,Skye Bioscience Inc.股市,Skye Bioscience Inc.股票价格,Skye Bioscience Inc.股票交易,Skye Bioscience Inc.股票购买,Skye Bioscience Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Skye Bioscience Inc.(SKYE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Skye Bioscience Inc.(SKYE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}